Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Calgary

$135,000.00

The Endocannabinoid System in Glucocorticoid-Induced Metabolic Outcomes: A Focus on Genetic Variants of Fatty Acid Amide Hydrolase

FY 2017-18

Summary
Chronic stress, with a rise in stress hormones known as glucocorticoids (GCs, cortisol in humans), is a major risk factor for obesity. Evidence suggests that GC actions underlie the effects of chronic stress on energy balance. Yet the relationship between stress, GCs, and energy balance is highly complex. For example when confronted with stress, some individuals gain weight, whereas others lose weight. It is believed that an individual's response to stress and GCs is moderated by genetic variants. Nevertheless, genetic risk factors remain elusive. In humans, there is a common genetic variant in the gene for fatty acid amide hydrolase (FAAH), present in ~38% of Europeans. This genetic variant (C385A) reduces levels of FAAH to ultimately affect the endocannabinoid system, since FAAH breaks down the endocannabinoid ligand anandamide. Thus, carriers of this variant exhibit tonically elevated levels of anandamide. Indeed anandamide regulates energy balance and the stress response. Importantly, the low-expressing FAAH variant (A-allele carriers) has been associated with improved stress coping and increased rates of obesity in humans. Thus, the FAAH variant is positioned to moderate stress-induced metabolic outcomes. This project will be the first to examine whether genetic variants of FAAH predict individual susceptibility to obesity in response to chronic GC exposure. We will employ a mouse model, which recapitulates the common human mutation in the FAAH gene (C385A), to investigate the effects of differential FAAH expression (between C- and A-allele carriers) on feeding and energy expenditure. This project has the potential to establish a molecular link between energy balance and stress, and may help to explain why diverging metabolic outcomes arise when confronted with stress. Together, the outcomes of these studies may improve our understanding of the biological basis underlying the varying relationship that exists between stress and obesity.
Program
CIHR Fellowship
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376136
Name
Balsevich Georgia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The Endocannabinoid System in Glucocorticoid-Induced Metabolic Outcomes: A Focus on Genetic Variants of Fatty Acid Amide Hydrolase
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Endocannabinoids; Energy Balance; Fatty Acid Amide Hydrolase; Feeding; Genetic Risk Factors; Glucocorticoids; Mouse Models; Stress
Abstract
Chronic stress, with a rise in stress hormones known as glucocorticoids (GCs, cortisol in humans), is a major risk factor for obesity. Evidence suggests that GC actions underlie the effects of chronic stress on energy balance. Yet the relationship between stress, GCs, and energy balance is highly complex. For example when confronted with stress, some individuals gain weight, whereas others lose weight. It is believed that an individual's response to stress and GCs is moderated by genetic variants. Nevertheless, genetic risk factors remain elusive. In humans, there is a common genetic variant in the gene for fatty acid amide hydrolase (FAAH), present in ~38% of Europeans. This genetic variant (C385A) reduces levels of FAAH to ultimately affect the endocannabinoid system, since FAAH breaks down the endocannabinoid ligand anandamide. Thus, carriers of this variant exhibit tonically elevated levels of anandamide. Indeed anandamide regulates energy balance and the stress response. Importantly, the low-expressing FAAH variant (A-allele carriers) has been associated with improved stress coping and increased rates of obesity in humans. Thus, the FAAH variant is positioned to moderate stress-induced metabolic outcomes. This project will be the first to examine whether genetic variants of FAAH predict individual susceptibility to obesity in response to chronic GC exposure. We will employ a mouse model, which recapitulates the common human mutation in the FAAH gene (C385A), to investigate the effects of differential FAAH expression (between C- and A-allele carriers) on feeding and energy expenditure. This project has the potential to establish a molecular link between energy balance and stress, and may help to explain why diverging metabolic outcomes arise when confronted with stress. Together, the outcomes of these studies may improve our understanding of the biological basis underlying the varying relationship that exists between stress and obesity.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Balsevich, Georgia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~